mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.074 |
0.2 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.2 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.2 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |